ATE382372T1 - Erhöhte t-zell tumor-eindringung durch light- mutanten - Google Patents

Erhöhte t-zell tumor-eindringung durch light- mutanten

Info

Publication number
ATE382372T1
ATE382372T1 AT04776477T AT04776477T ATE382372T1 AT E382372 T1 ATE382372 T1 AT E382372T1 AT 04776477 T AT04776477 T AT 04776477T AT 04776477 T AT04776477 T AT 04776477T AT E382372 T1 ATE382372 T1 AT E382372T1
Authority
AT
Austria
Prior art keywords
investment
increased
cell tumor
light
mutants
Prior art date
Application number
AT04776477T
Other languages
English (en)
Inventor
Yang-Xin Fu
Original Assignee
Univ Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chicago filed Critical Univ Chicago
Application granted granted Critical
Publication of ATE382372T1 publication Critical patent/ATE382372T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04776477T 2003-06-11 2004-06-10 Erhöhte t-zell tumor-eindringung durch light- mutanten ATE382372T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47773303P 2003-06-11 2003-06-11
US47812603P 2003-06-12 2003-06-12

Publications (1)

Publication Number Publication Date
ATE382372T1 true ATE382372T1 (de) 2008-01-15

Family

ID=33567565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776477T ATE382372T1 (de) 2003-06-11 2004-06-10 Erhöhte t-zell tumor-eindringung durch light- mutanten

Country Status (9)

Country Link
US (1) US7807784B2 (de)
EP (1) EP1641491B1 (de)
JP (1) JP5049011B2 (de)
AT (1) ATE382372T1 (de)
AU (1) AU2004253465A1 (de)
CA (1) CA2529058A1 (de)
DE (1) DE602004011061T2 (de)
ES (1) ES2297479T3 (de)
WO (1) WO2005002628A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811983B2 (en) * 2003-06-11 2010-10-12 The University Of Chicago Increased T-cell tumor infiltration and eradication of metastases by mutant light
WO2007003216A1 (en) * 2005-07-06 2007-01-11 Universidad Autónoma de Madrid Anti-ccr7 receptor antibodies for the treatment of cancer
WO2008098183A2 (en) * 2007-02-08 2008-08-14 The University Of Chicago Combination therapy for treating cancer
WO2008144029A1 (en) 2007-05-14 2008-11-27 The University Of Chicago Antibody-light fusion products for cancer therapeutics
CN104151434B (zh) * 2008-05-07 2018-12-04 苏州丁孚靶点生物技术有限公司 预防和治疗原发和转移性癌症的light-抗肿瘤抗原抗体
US8263823B2 (en) * 2008-10-20 2012-09-11 Adimmu Institute Inc. Immunocompetent xenograft model
JP2012507299A (ja) 2008-10-31 2012-03-29 バイオジェン・アイデック・エムエイ・インコーポレイテッド Light標的分子およびその使用
AU2012352454A1 (en) 2011-12-15 2014-07-17 The University Of Chicago Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
CN116083435A (zh) * 2022-11-04 2023-05-09 吉林大学 以人源light截短型突变蛋白为基础的抗肿瘤的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
ATE229810T1 (de) 1996-10-11 2003-01-15 Univ California Krebs immuntherapie unter verwendung von tumorzellen kombiniert mit lymphozytmischungen
US6048551A (en) 1997-03-27 2000-04-11 Hilfinger; John M. Microsphere encapsulation of gene transfer vectors
US6140467A (en) * 1997-07-07 2000-10-31 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
US6475986B1 (en) * 1999-02-02 2002-11-05 Research Development Foundation Uses of THANK, a TNF homologue that activates apoptosis
WO2001079496A2 (en) * 2000-03-13 2001-10-25 La Jolla Institute For Allergy And Immunology Ligand for herpes simplex virus entry mediator and methods of use
WO2002032463A1 (en) 2000-10-18 2002-04-25 Smithkline Beecham Corporation Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules
WO2002034780A2 (en) 2000-10-26 2002-05-02 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Hetero-oligomeric compounds derived from the tnf cytokine superfamily and their use
WO2003040307A2 (en) 2001-07-27 2003-05-15 Human Genome Sciences, Inc. Heteromultimeric tnf ligand family members

Also Published As

Publication number Publication date
JP2007516694A (ja) 2007-06-28
CA2529058A1 (en) 2005-01-13
AU2004253465A1 (en) 2005-01-13
DE602004011061T2 (de) 2008-11-06
US7807784B2 (en) 2010-10-05
ES2297479T3 (es) 2008-05-01
EP1641491B1 (de) 2008-01-02
WO2005002628A1 (en) 2005-01-13
US20050025754A1 (en) 2005-02-03
EP1641491A1 (de) 2006-04-05
JP5049011B2 (ja) 2012-10-17
DE602004011061D1 (de) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2004007679A3 (en) Dendritic cell pontentiation
MY162559A (en) Human anti-il-23 antibodies, compositions, methods and uses
WO2005005601A8 (en) Compositions and methods for treating and diagnosing cancer
NZ596494A (en) Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells
WO2009014708A3 (en) Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
WO2007126805A3 (en) Cancer immunotherapy compositions and methods of use
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
WO2004087896A3 (en) Hepatocyte differentiation of stem cells
DE602004011061D1 (de) Erhöhte t-zell tumor-eindringung durch light- mutanten
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
WO2005044792A3 (en) Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
ATE526394T1 (de) Verfahren zur expansion von cd4+ cd25+ t regulatory zellen
DK1495112T3 (da) Cellekulturmedium
IL217561A0 (en) Use of cytokininis to increase the ratio of wild type to mutant protein in cells
EP1537229A4 (de) Verfahren zur herstellung biologischer substanzen in pigmentmangelmutanten von bacillus-zellen
EP1355151A3 (de) Bewertung von kolorektalem Krebs
WO2004003493A3 (en) Methods and kits for determining energy expenditure in living organisms by metabolic water production
EP1355149A3 (de) Bewertung von kolorektalem Krebs
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
EP2484759A3 (de) Verfahren zur Neufaltung von Säuger-Glykosyltransferasen
DE60323267D1 (en) Rna-bioassay
WO2006124375A3 (en) Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
WO2004035801A3 (de) Enzymatische polymerisation von miniemulsionen
DK1458853T3 (da) Fremgangsmåde til donorspecifik krydsmatchning
NZ534256A (en) Development and stratification of pine embryos using a liquid system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties